ATE547110T1 - Verwendung von zellen aus fettgewebe zur herstellung eines antitumoralen medikaments - Google Patents

Verwendung von zellen aus fettgewebe zur herstellung eines antitumoralen medikaments

Info

Publication number
ATE547110T1
ATE547110T1 AT07731481T AT07731481T ATE547110T1 AT E547110 T1 ATE547110 T1 AT E547110T1 AT 07731481 T AT07731481 T AT 07731481T AT 07731481 T AT07731481 T AT 07731481T AT E547110 T1 ATE547110 T1 AT E547110T1
Authority
AT
Austria
Prior art keywords
cells
produce
fat tissue
antitumoral drug
antitumoral
Prior art date
Application number
AT07731481T
Other languages
English (en)
Inventor
Pierre Cordelier
Louis Buscail
Louis Casteilla
Beatrice Cousin-Delarue
Luc Penicaud
Jean-Marie Peron
Original Assignee
Centre Nat Rech Scient
Univ Toulouse 3 Paul Sabatier
Inst Nat Sante Rech Med
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37441815&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE547110(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Centre Nat Rech Scient, Univ Toulouse 3 Paul Sabatier, Inst Nat Sante Rech Med filed Critical Centre Nat Rech Scient
Application granted granted Critical
Publication of ATE547110T1 publication Critical patent/ATE547110T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A61K48/0008—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'non-active' part of the composition delivered, e.g. wherein such 'non-active' part is not delivered simultaneously with the 'active' part of the composition
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/35—Fat tissue; Adipocytes; Stromal cells; Connective tissues
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0662—Stem cells
    • C12N5/0667—Adipose-derived stem cells [ADSC]; Adipose stromal stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2502/00—Coculture with; Conditioned medium produced by
    • C12N2502/30—Coculture with; Conditioned medium produced by tumour cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Wood Science & Technology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Rheumatology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT07731481T 2006-05-18 2007-05-18 Verwendung von zellen aus fettgewebe zur herstellung eines antitumoralen medikaments ATE547110T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0604443A FR2901136B1 (fr) 2006-05-18 2006-05-18 Utilisation de cellules derivees du tissu adipeux pour la preparation d'un medicament anti-tumoral
PCT/FR2007/000847 WO2007135284A1 (fr) 2006-05-18 2007-05-18 Utilisation de cellules derivees du tissu adipeux pour la preparation d'un medicament anti-tumoral

Publications (1)

Publication Number Publication Date
ATE547110T1 true ATE547110T1 (de) 2012-03-15

Family

ID=37441815

Family Applications (1)

Application Number Title Priority Date Filing Date
AT07731481T ATE547110T1 (de) 2006-05-18 2007-05-18 Verwendung von zellen aus fettgewebe zur herstellung eines antitumoralen medikaments

Country Status (8)

Country Link
US (1) US20090186007A1 (de)
EP (1) EP2040719B1 (de)
JP (1) JP5406017B2 (de)
AT (1) ATE547110T1 (de)
CA (1) CA2652365C (de)
ES (1) ES2383546T3 (de)
FR (1) FR2901136B1 (de)
WO (1) WO2007135284A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8105580B2 (en) 2001-12-07 2012-01-31 Cytori Therapeutics, Inc. Methods of using adipose derived stem cells to promote wound healing
US9597395B2 (en) 2001-12-07 2017-03-21 Cytori Therapeutics, Inc. Methods of using adipose tissue-derived cells in the treatment of cardiovascular conditions
US8404229B2 (en) 2001-12-07 2013-03-26 Cytori Therapeutics, Inc. Methods of using adipose derived stem cells to treat acute tubular necrosis
US20050095228A1 (en) 2001-12-07 2005-05-05 Fraser John K. Methods of using regenerative cells in the treatment of peripheral vascular disease and related disorders
KR100811995B1 (ko) 2001-12-07 2008-03-10 사이토리 테라퓨틱스, 인크. 처리된 리포애스퍼레이트 세포로 환자를 치료하기 위한시스템 및 방법
US7585670B2 (en) 2001-12-07 2009-09-08 Cytori Therapeutics, Inc. Automated methods for isolating and using clinically safe adipose derived regenerative cells
US7771716B2 (en) 2001-12-07 2010-08-10 Cytori Therapeutics, Inc. Methods of using regenerative cells in the treatment of musculoskeletal disorders
WO2010021993A1 (en) 2008-08-19 2010-02-25 Cytori Therapeutics, Inc. Methods of using adipose tissue-derived cells in the treatment of the lymphatic system and malignant disease
WO2014000029A1 (en) * 2012-06-26 2014-01-03 Rusty Property Holdings Pty Ltd Compositions and methods for reducing frequency and/or severity of headache
KR102081239B1 (ko) 2018-09-10 2020-02-25 고려대학교 산학협력단 Timp-1 및 timp-2를 유효성분으로 함유하는 기형종 형성 및 성장 억제용 조성물

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL145002A0 (en) * 1999-03-10 2002-06-30 Univ Pittsburgh Adipose-derived stem cells and lattices
US20030082152A1 (en) 1999-03-10 2003-05-01 Hedrick Marc H. Adipose-derived stem cells and lattices
US6372494B1 (en) * 1999-05-14 2002-04-16 Advanced Tissue Sciences, Inc. Methods of making conditioned cell culture medium compositions
US6555374B1 (en) * 1999-08-19 2003-04-29 Artecel Sciences, Inc. Multiple mesodermal lineage differentiation potentials for adipose tissue-derived stromal cells and uses thereof
PT1261694E (pt) * 2000-02-26 2008-04-03 Artecel Inc Células estaminais pluripotentes produzidas a partir de células estromais derivadas de tecido adiposo e suas utilizações.
CA2406664C (en) * 2000-03-15 2011-05-10 Children's Medical Center Corporation Systemic delivery of neural stem cells to treat cancer
FR2819265B1 (fr) * 2001-01-10 2004-01-02 Centre Nat Rech Scient Cellules du tissu adipeux extramedullaire et leurs applications dans la reconstitution des lignees hematopoietiques
EP1453954A4 (de) * 2001-11-09 2004-12-15 Artecel Sciences Inc Endokrine pankreasdifferenzierung von aus fettgewebe stammenden stromazellen und ihre verwendung
EP1456354A4 (de) * 2001-11-09 2005-11-09 Artecel Sciences Inc Aus fettgewebe stammende stromazellen zur reparatur von hornhaut- und intraorbital-defekten und verwendungen davon
AU2003213666A1 (en) * 2002-03-02 2003-09-16 Board Of Regents, The University Of Texas System Local production and/or delivery of anti-cancer agents by stromal cell precursors
FR2859381B1 (fr) * 2003-09-05 2008-07-25 Centre Nat Rech Scient Utilisaton de cellules issues du tissu adipeux pour induire la formation d'un reseau vasculaire fonctionnel
DE602004030823D1 (de) * 2003-11-04 2011-02-10 Biomaster Inc Verfahren und system zur herstellung von stammzellen aus fettgewebe
EP2597149A1 (de) * 2004-08-16 2013-05-29 CellResearch Corporation Pte Ltd Isolierung, Kultivierung und Verwendungen von Stamm- bzw. Vorläuferzellen

Also Published As

Publication number Publication date
CA2652365C (fr) 2014-05-13
JP5406017B2 (ja) 2014-02-05
ES2383546T3 (es) 2012-06-22
EP2040719B1 (de) 2012-02-29
WO2007135284A1 (fr) 2007-11-29
FR2901136B1 (fr) 2010-10-01
EP2040719A1 (de) 2009-04-01
FR2901136A1 (fr) 2007-11-23
JP2009537493A (ja) 2009-10-29
US20090186007A1 (en) 2009-07-23
CA2652365A1 (fr) 2007-11-29

Similar Documents

Publication Publication Date Title
NZ622566A (en) Chromobacterium bioactive compositions and metabolites
EP2424975A4 (de) Organismen zur herstellung von 1,3-butandiol
AU2007257423A8 (en) Purine analogs
WO2009151907A3 (en) Compositions and methods for using cells to treat heart tissue
EP4234698A3 (de) Zusammensetzungen und verfahren zur verwendung von therapeutischen antikörpern gegen ldl-assoziiertes protein 6 (lrp6)
WO2006050330A3 (en) Platelets from stem cells
EP2019316A3 (de) Menschliches ex-vivo-Hautmodell
WO2010141803A3 (en) Bioartificial lung
FR2964565B1 (fr) Composition cosmetique comprenant un polymere fixant et un agent antipelliculaire
TN2012000512A1 (en) Compositions and methods of use for therapeutic low density lipoprotein - related protein 6 (lrp6) multivalent antibodies
MY159971A (en) Multipotent/pluripotent cells and methods
AU2008235089A8 (en) Insecticidal aryl isoxazoline derivatives
WO2012003377A3 (en) Methods of preparing chorion tissue and products derived therefrom
WO2012027402A3 (en) Patient-matched instruments
WO2008085221A3 (en) Therapeutic use of cd31 expressing cells
WO2008027420A3 (en) Implantable devices for producing insulin
ATE543519T1 (de) Verwendung eines hämoglobins zur herstellung von verbänden und daraus resultierende verbände
EA200802214A1 (ru) 2,4-диаминопиримидины в качестве ингибиторов киназ, участвующих в регуляции клеточного цикла
MX2009009006A (es) Agonistas ppar-gamma para la induccion de expresion de peptido antimicrobiano cationico en la forma de estimulantes inmunoprotectores.
BR112013025047A2 (pt) composições nutricionais para aumentar os níveis de arginina e métodos para usar as mesmas
EA200870515A1 (ru) Моноциклические гетероарильные соединения
CR11810A (es) Compuestos de 1,2-benzotiazolo utiles para combatir plagas animales
GEP20135800B (en) Method of 1-(2-halobiphenyl-4-yl)-cyclopropanecarboxylic acid derivatives preparation
WO2010054757A3 (de) Wirkstoffkombinationen mit insektiziden und akariziden eigenschaften
EP4595990A3 (de) Röhrenförmige prothesen